INT190000

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.01
First Reported 2006
Last Reported 2006
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0.09
Pain Relevance 0.19

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

aging (Slc6a3) small molecule metabolic process (MVD) lyase activity (MVD)
endoplasmic reticulum (Ubqln1) peroxisome (MVD) protein complex (Ubqln1)
Anatomy Link Frequency
synaptic cleft 2
MVD (Homo sapiens)
Slc6a3 (Rattus norvegicus)
Ubqln1 (Rattus norvegicus)
Pain Link Frequency Relevance Heat
Dopamine 30 100.00 Very High Very High Very High
addiction 2 48.32 Quite Low
Eae 13 43.20 Quite Low
cocaine 3 23.08 Low Low
Nucleus accumbens 36 14.96 Low Low
Ventral tegmentum 37 14.76 Low Low
Central nervous system 5 5.00 Very Low Very Low Very Low
anesthesia 3 5.00 Very Low Very Low Very Low
drug abuse 2 5.00 Very Low Very Low Very Low
Neurotransmitter 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Cognitive Disorder 5 93.24 High High
Drug Dependence 3 48.32 Quite Low
Attention Deficit Hyperactivity Disorder 13 38.68 Quite Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The binding of MPD to dopamine transporter (DAT) increases DA in the synaptic cleft in intraperitoneal administration [67,68]; while oral MPD application elevates mainly norepinephrine (NE), in addition to DA [68], which improves cognitive function through ?
MPD Binding (binding) of DAT in synaptic cleft Positive_regulation (increases) of DA associated with cognitive disorder and dopamine
1) Confidence 0.01 Published 2006 Journal Behav Brain Funct Section Body Doc Link PMC1360669 Disease Relevance 0.09 Pain Relevance 0.19

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox